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Swine Influenza A virus subtype H1N2 in Sweden   
Abstract 
The  influenza  A  virus  subtypes  H1N1,  H1N2  and  H3N2  are  prevalent  in  pig 
populations worldwide. All scientific data point towards swine as the key host species 
when  new  human  influenza  pandemics  arise.  All  previous  pandemics  have  been 
suggested  to  evolve  in  pigs  from  viral  genes  of  avian,  human  and  porcine  origin. 
Therefore, it is of major importance to monitor the evolution of swine influenza viruses 
in pigs, and in particular monitor hallmarks of species adaptation to humans.  
The scope of this project was to increase the understanding of the genetics of swine 
influenza  virus  (SIV),  with  special  emphasis  on  its  zoonotic  potential,  and  to 
investigate the importance of different viral gene markers for species specificity and 
adaptation.  
Since clinical manifestation of swine influenza is rare in Sweden, and SIV strains are of 
particular concern due to the novel human H1N1 epidemic, viruses were isolated in 
primary  swine  kidney  or  Madin  Darby  Canine  Kidney  (MDCK)  cells,  based  on 
standard  protocols  and  the  isolates  were  subjected  to  full  genome  sequencing  and 
comparative sequence analysis of the viral genomes.  
The  results  describe  the  analysis  of  the  whole  genome  sequences  from  two  swine 
influenza  viruses  isolated  from  Sweden  in  2009  and  2010.  Moreover,  this  study 
demonstrates,  for  the  first  time,  natural  reassortment  in  H1N2  viruses  in  the  pig 
populations  of  Sweden.  Biological  characterization  of  the  two  viruses  revealed  a 
weaker  growing  potential,  compared  to  the  Swedish  2002  H1N1  isolate.  Sequence 
comparison  revealed  significant  differences  between  the  two  consecutive  H1N2 
isolates. The most remarkable of these was a truncated coding region for PB1-F2 in the 
earlier isolates and a full length coding region in the more recent isolates.  
In order to determine the effect of these viruses on the swine industry and on influenza 
ecology, further surveillance investigations and detailed analyses are needed. 
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1  Introduction  
 
1.1  History and epidemiological evolution of European swine 
influenza viruses 
Influenza is a highly contagious acute respiratory illness that appears to have 
caused serious disease in humans since ancient times. It is a viral illness of 
global  importance,  caused  by  the  influenza  virus.  Influenza  viruses  were 
probably  responsible  for  the  disease  described  by  Hippocrates  in  412  BC 
(Hoehling,  1961),  and  are  still  causing  significant  mortality  and  morbidity 
throughout the world. Influenza viruses can infect many animal species and 
some of these viruses may give rise to pandemic strains in humans. One recent 
example is the case of the 2009 H1N1 pandemic (H1N1pdm). Most threatening 
is  the  possibility  of  another  pandemic  appearing,  similar  to  the  Spanish 
influenza  of  1918,  which  cost  more  than  40  million  lives  (Palese,  2004; 
Johnson & Mueller, 2002; Hoehling, 1961).   
Influenza  viruses  have  been  isolated  from  avian  species  and  mammals, 
including humans and pigs. Swine influenza viruses (SIV) cause respiratory 
disease in pigs and can have a significant economic impact in an affected herd. 
Swine influenza (SI) was first clinically recognized at the time of the Spanish 
influenza pandemic of 1918 but the virus was not isolated and identified by 
Shope  until  1930.  It  was  shown  to  be  an  influenza  A  virus  of  the  H1N1 
antigenic subtype called classical H1N1 (Shope, 1931). It was probably exactly 
the same virus affecting both humans and pigs. Nowadays three main subtypes 
of SIV are prevalent in pig populations worldwide, H1N1, H3N2 and H1N2 
(Karasin  et  al.,  2002;  Gourreau  et  al.,  1994),  responsible  for  a  highly 
contagious respiratory disease in pigs (Brown, 2000). The origin and nature of 
SIVs differ on different continents (Olsen et al., 2005). These differences have   12 
implication  for  the  diagnosis  and  control  of  SIV,  e.g.  the  strains  used  as 
antigens  in  vaccines  and  diagnostic  test  are  different  in  Europe  and  in  the 
United States. Also, the influenza virus can be one of many components in 
association  with  the  porcine  respiratory  disease  complex,  of  multifactorial 
aetiology (Hansen et al., 2010). In the epidemic form of the disease SIV moves 
swiftly in all parts of the swine unit as it is readily transmitted by contact with 
respiratory  secretions  as  well  as  by  aerosol.  Infection  causes  coughing, 
sneezing, nasal discharge, fever, lethargy, breathing difficulty and depressed 
appetite, and can lead to morbidity rates of up to 100% (Olsen et al., 2006). 
Mortality is on the other hand low and recovery is unusually rapid, occurring 
within 7–10 days. 
1.1.1  Classical H1N1 
In Europe, SIVs were first isolated in Great Britain between 1938 and 1940 
(Blakemore & Gledhill, 1941; Lamont, 1938). Nucleotide sequence analysis 
has shown that all eight genome segments of these strains were more closely 
related  to  the  early  human  H1N1  strains  A/Wisconsin/33  and  A/Puerto 
Rico/8/34 than to the classical swine H1N1 virus (A/Sw/Iowa/1930), which 
was isolated in pigs in the US by Shope (Neumeier et al., 1994). In 1950, the 
classical swine H1N1 virus was isolated in Czechoslovakia but after that no 
SIV detection was reported in Europe for more than two decades (Dunham et 
al.,  2009;  Kuntz-Simon  &  Madec,  2009).  Classical  swine  H1N1  viruses 
circulated in North America but were absent in Europe until 1976, when they 
were isolated from pigs imported to Italy from the United States (Nardelli et 
al., 1978). After that, H1N1 spread and became established in other European 
countries, e.g. in the Netherlands (Masurel et al., 1983), Denmark (Johnsen, 
1985; Sorensen et al., 1981), and southern Sweden in 1983 (Abusugra et al., 
1987) and in the United Kingdom (Roberts et al., 1987). In North America and 
Asia the classical swine H1N1 is still the most common isolate but in Europe 
the H1N1 in pigs is now predominantly of avian origin (Guan et al., 1996; 
Hinshaw et al., 1978). 
1.1.2  “Avian-like” H1N1’ 
The predominant H1N1 SIVs in Europe are of wholly avian genome origin, 
and were introduced from wild ducks to the pig population in 1979 (Campitelli 
et al., 1997; Pensaert, 1981). They are called “avian-like” swine H1N1 viruses 
and  are  antigenically  distinguishable  from  classical  swine  H1N1  influenza 
viruses. These “avian-like” viruses have a selective advantage over classical 
swine  H1N1  viruses  that  are  antigenically  related,  as  in  Europe  they  have 
replaced the classical SI virus (Brown, 2000; Campitelli et al., 1997). After two   13 
years of circulation of the “avian-like” viruses in the pig population in Great 
Britain, the classical H1N1 virus disappeared as a clinical entity. 
1.1.3  Human-like H3N2 
In the early 1970s, H3N2 viruses resembling the H3N2 strain responsible for 
the  human  1968  Hong  Kong  influenza  pandemic  were  introduced  into 
European pigs (Harkness et al., 1972).  In 1984 a reassortment event occurred, 
resulting in a new strain containing human-like H3N2 “Hong Kong influenza 
virus” surface genes (HA, NA) and the internal genes of “avian-like” H1N1 
(Campitelli et al., 1997), and this replaced the original human-like swine H3N2 
“Hong Kong influenza 1968” strain in circulation among pig populations in 
European  countries  in  the  1990s  (Kuntz-Simon  &  Madec,  2009).  The 
occurrence and prevalence of SIVs vary among the different regions in Europe, 
but  the  avian  origin  H1N1  appears  to  be  the  most  predominant  subtype, 
followed by reassortant H3N2 and to a lower extent the H1N2 subtypes, which 
comprise viruses of diverse genetic constellations. 
1.1.4  H1N2 
As a result of further reassortment events, the first European SI H1N2 subtype 
was  reported  in  France  in  1987  (Gourreau  et  al.,  1994).  This  virus  was  a 
reassortant  between  the  avian-like  swine  H1N1  virus  and  the  European 
reassortant human-like swine H3N2. This virus has the haemagglutinin (HA) 
gene of avian and the neuraminidase (NA) gene of human origin. The first 
European SI H1N2 subtype did not become widespread in the European pig 
populations.  However,  another  distinct  lineage  of  H1N2  virus  did  become 
widespread in European pig populations, by a reassortant variant of “human-
like” H1N2 virus identified in the UK in 1994. This virus spread to Belgium 
and other European countries during the next few years and became endemic 
(Marozin  et  al.,  2002;  Van  Reeth  et  al.,  2000;  Brown  et  al.,  1995).  This 
reassortant was the result of a reassortment between a human H1N1 virus from 
the 1980s (HA protein), the “human-like” swine H3N2 virus (NA protein) and 
the  “avian-like  swine”  H1N1  SIV,  from  which  it  “inherited”  the  internal 
protein  genes  (Brown  et  al.,  1998).  These  viruses  are  genetically  and 
antigenically different from viruses of the same subtype that had been present 
in  pigs  in  France  in  1987.  Since  1998  reassortant  H1N2  SIVs  have  been 
isolated  in  Italy  and  France  (Kuntz-Simon  &  Madec,  2009; Marozin  et  al., 
2002). They are similar to the prototype H1N2 strains; the difference is that 
instead of a human HA, they have the “avian-like” HA from H1N1 SIVs.  
In Denmark an H1N2 influenza subtype was discovered for the first time in 
2003.  All  H1N2  viruses  found  in  Denmark  are  reassortants  of  “avian-like”   14 
H1N1 and “human-like” H3N2 SIVs (Hjulsager et al., 2006). In 2009 and 2010 
there  were  the  first  reported  isolations  and  demonstrations  of  natural 
reassortants  of  H1N2  viruses  in  pigs  in  Sweden  (Balint  et  al.,  2009).  The 
characterized  Swedish  isolates  possessed  avian-like  SIV  H1N1  HA  and 
European H3N2 SIV-like NA (Metreveli et al., 2011).  
1.1.5  Epidemiology  
Continuous  circulation  of  influenza  A  viruses  in  pigs  can  result  in  the 
production  of  new  reassortant  viruses.  These  reassortants  cannot  always 
become established in an immunologically naïve pig population. In Europe, 
other subtypes have sporadically been isolated and then disappeared from pigs. 
For  example,  subtype  H1N7  (human  and  equine)  in  1992  from  England 
(Brown et al., 1997) and H3N1 reported from Italy (Moreno et al., 2009) have 
been isolated but have not been established in the pig population. These novel 
subtypes have not been widespread either in Great Britain or in the Italian pig 
population. This could be explained by the budding interplay activities of H3 
and N1 and H1 and N7 proteins are not being as well functionally balanced as 
are the H1 and N2 proteins. In North America and Asia, many other subtypes 
have  been  described  in  pigs  (H4N6,  H3N3,  H9N2,  H5N1,  H2N3),  but  no 
evidence has been found of such viruses circulating in European pigs. It is 
widely accepted that wild aquatic birds are reservoirs of all influenza A viruses 
for other species (Fouchier et al., 2005). Due to their susceptibility to both 
human and avian influenza A viruses (Ito et al., 1998; Webster et al., 1992), 
swine  have  been  postulated  to  play  an  important  role  in  interspecies 
transmission, by acting as a mixing vessel for reassortment between viruses 
specific to different host species (Scholtissek, 1994), which is an important 
mechanism in the evolution of human pandemics (Webster et al., 1992). This 
has  been  verified  in  Europe,  in  Italian  pigs,  when  (Castrucci  et  al.,  1993) 
detected reassortment of human and avian viruses, and it is best exemplified by 
the appearance of the 2009 H1N1pdm influenza virus (Fig 1). Pigs were found 
to  be  susceptible  to  the  2009  H1N1pdm,  which  was  transmitted  to  pigs  in 
several countries. 
The  classical  swine  influenza  virus  lineage  became  established  in  domestic 
pigs in 1918-1920, similar to the 1918 pandemic H1N1virus. In 1979 “avian-
like”  H1N1  virus  appeared  in  European  pigs  and  was  circulating  with  the  
classical  swine  H1N1  viruses.  In  1998,  a  North  American  triple  H3N2 
reassortant virus was reported in the United States, derived from three different 
origins:  an  avian  virus  that  circulated  in  wild  birds,  classical  swine  H1N1 
viruses, and a human H3N2 influenza virus. This triple reassortant swine origin 
influenza virus became predominant in the North American pig population.   15 
These are the viruses that provided genomic segments for the 2009 H1N1pdm 
virus.  This  2009  H1N1pdm  virus  has  PB2  and  PA  segments  from  North 
American avian viruses: the PB1 segment is from the human H3N2 viruses, 
(from the 1968 pandemic, whose PB1 segment is of avian origin), the HA (of 
the H1 subtype), NP and NS segments are from classical swine H1N1 viruses 
(also avian origin), and the NA (of the N1 subtype) and M segments are from 
Eurasian 1979 “avian-like” swine viruses. 
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Figure 1. Emergence of the 2009 pandemic H1N1 virus. This 2009 H1N1pdm virus has PB2 and 
PA segments from North American avian viruses, the PB1 segment is from the human H3N2 
viruses, (from the 1968 pandemic whose PB1 segment is of avian origin), the HA (of the H1 
subtype), NP and NS are segments are from classical swine H1N1 viruses (also avian origin), and 
the NA (of the N1 subtype) and M segments are from Eurasian 1979 “avian-like” swine viruses. 
The circulation of SIVs in Asia is more complex than it is elsewhere. Some 
SIVs  of  the  North  American  and  European  lineages  have  been  found  and 
detected in Asia; this could be the reason of importation of live pigs from these 
regions but there are several lineages that are found only in Asia. It is not so 
surprising,  therefore,  that  the  circulation  of  entirely  avian  influenza  (AI) 
viruses in pigs in nature is a relatively rare event. Still, there is circumstantial 
evidence that the genes of avian viruses may persist after reassortment with 
one  or  more  influenza  viruses  endemic  in  pigs.  As  an  example,  H3N2  and 
H1N2 influenza viruses carrying mixtures of avian, swine and human influenza   16 
virus genes have become enzootic in Europe. This probably means that genetic 
reassortments  or  mutations  are  needed  for  successful  transmission  of  AI 
viruses  between  pigs.  Therefore  it  is  of  major  importance  to  monitor  the 
evolution  of  SI  in  pigs,  and  in  particular  monitor  the  hallmarks  of  species 
adaptation to humans. 
1.2  Influenza virus biology, genome structure and organization  
1.2.1  Classification  
Influenza viruses A, B and C together with Thogotovirus, Isavirus and newly 
discovered Quaranfilvirus are genera in the family of Orthomyxoviridae (Perez 
et al., 2011). The name of the family is derived from Greek – orthos, which 
means correct or right and myxa, which means mucus. The influenza A, B and 
C viruses have antigenic differences in their nucleoproteins (NP) and matrix 
proteins (M) (Lamb & Krug, 2001). Influenza type B and C occur in humans, 
although  not  exclusively;  influenza  C  virus  has  been  isolated  from  swine 
(Yuanji & Desselberger, 1984) and influenza B virus from seals (Osterhaus et 
al.,  2000).  Influenza  A  viruses  have  been  isolated  from  a  large  variety  of 
animals, including humans, pigs, mink, horses, dogs, sea mammals and birds 
(Webster et al., 1992; Alexander, 1982) and can cause serious disease with 
pandemic characteristics. 
Influenza A viruses are further divided into subtypes based on the antigenic 
properties  of  the  external  glycoproteins,  haemagglutinin  (HA)  and 
neuraminidase (NA). Sixteen antigenically different HAs (H1–H16) and nine 
different NAs (N1–N9) have been identified and their combination designates 
the subtype of the virus (Fouchier et al., 2005; Alexander, 2000). Recently a 
new subtype H17 was discovered in Central American bats (Gewin, 2012). It is 
widely accepted that wild aquatic birds like ducks, gulls, and seabirds, are the 
most  important  reservoir  of  these  viruses,  because  influenza  viruses  of  all 
possible subtypes have been identified in this population. It is thought that they 
are  the  source  of  viruses  that  infect  other  avian  and  mammalian  species. 
Influenza virus strains are given names according to their type (A, B or C), 
host (from where the virus was isolated), geographic location, number of the 
isolate, the year of isolation and HA and NA subtypes, for example: the first 
isolate  of  an  H1N2  subtype  virus  isolated  from  pig  in  Sweden  in  2009  is 
named: A/swine/Sweden/1021/2009(H1N2). 
1.2.2  Virion structure  
Influenza A virions are enveloped and pleomorphic. Their shape varies from 
small and spherical (cell culture isolates) with a diameter of about 100 nm, to   17 
long and filamentous of more than 300 nm, which was observed especially in 
fresh clinical isolates (Chu et al., 1949) and in preparations of viruses with 
specific M1 or M2 proteins (Elleman & Barclay, 2004; Bourmakina & Garcia-
Sastre, 2003). The influenza A virus genome consists of eight single stranded, 
negative-sense RNAs that encode for 10–11 proteins, and eight are packaged 
into the infectious, enveloped virion (Palese & Shaw, 2007). The influenza A 
virus particle has a lipid membrane, derived from the host cell during the viral 
budding process (Cheung & Poon, 2007; Lamb & Krug, 2001; Webster et al., 
1992), and this where three viral proteins HA, NA and transmembrane protein 
M2  (Lamb  &  Krug,  2001)  are  inserted.  The  HA  and  NA  are  spike 
glycoproteins that are rod-shape and mushroom-shaped, respectively (Fig. 2). 
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Figure 2. Schematic graph of influenza A viruses. The genome consists of eight single-stranded 
RNAs that interact with nucleoprotein (NP) and components of the polymerase complex (PB2, 
PB1, PA). See text for details.   
The HA protein exists as a homotrimer, and it plays important roles in the 
influenza virus life cycle by mediating through receptor binding and membrane 
fusion. The cleavability of the HA protein by the host cell proteases determine 
the pathogenicity of influenza viruses. The NA protein is a homotetramer, and 
it plays a role in the release of virions by destroying receptors of the host and 
viral membranes. This is necessary for progeny virions to be released from the 
cell  surface.  The  transmembrane  protein  M2  functions  as  an  ion  channel   18 
(Holsinger et al., 1994; Wang et al., 1994), which has a role in virus entry, 
assembly and budding. Under the viral lipid envelope there is an M1 protein 
layer (Ruigrok et al., 1989). The ribonucleoprotein (RNP) complex is made up 
of  the  viral  RNA  segments,  three  polymerase  proteins  (basic  polymerase 
protein  2  (PB2),  basic  polymerase  protein  1  (PB1)  and  acidic  polymerase 
protein (PA) and the nucleoprotein (NP) (Shaw & Palese, 2008 ). The nuclear 
export protein (NEP; also called non-structural protein 2, NS2) is also present 
inside the viral particle (Palese & Shaw, 2006) and it functions as a nuclear 
export protein for vRNA in infected cells (O'Neill et al., 1998). Inside of the 
influenza A virion, all eight genomic RNAs (vRNA) are individually bound to 
the nucleoprotein (NP) and to the influenza virus RNA polymerase to form 
RNP complexes (Lamb & Choppin, 1983). Influenza A viruses increase the 
coding  capacity  of  their  genomes  by  splicing  and  using  alternative  open 
reading  frames.  Some  viral  isolates  can  express  the  PB1-F2  and  PB1  N40 
proteins encoded within the PB1 gene (Wise et al., 2009; Chen et al., 2001). 
The M and NS gene mRNAs are spliced, and thus can encode the M2 and the 
NS2 proteins, respectively (Lamb & Choppin, 1981; Lamb & Choppin, 1979).  
The PB1-F2 and NS1 proteins are the only non-structural proteins. Each viral 
gene has non-translated (NTR) regions at both the 5’ and 3’ ends that contain 
replication, transcription, and packaging signals. The 13 and 12 nucleotides 
(nt) at the 5’and 3’ ends, respectively, are conserved among all segments of 
influenza  A  viruses  (Palese  &  Shaw,  2006).  The  sizes  of  the  viral  RNA 
segments and the proteins encoded are shown in Table 1. 
Table 1. Genome segments of influenza A virus with encoded proteins, number of nucleotides and 
amino acids and function of virus protein. 
   
1          PB2                       2341           759   Polymerase   
 
2          PB1, PB1-F2/NP40          2341            757  Transcriptase, cell apoptosis  
 
3          PA                       2233           716  RNP release, ssRNA synthesis 
   
4          HA                      1778           566  Receptorbinding 
 
5          NP                      1565           498  Endocapsidate RNA (RNP) 
 
6          NA                      1423           454  Enzyme cleave sialic acid receptor 
 
7          M                      1027           252, 97  Capsid formation, ion channel 
Genome 
segments 
Virus 
encoded 
Nucleotide  Amino  
acid  
Functions 
8  NS, NEP 890 230, 121 mRNA splicing and transport control,
RNP nuclear transport   19 
1.3  Replication of influenza A viruses  
Replication  of  influenza  A  viruses  can  be  divided  into  the  following   
fundamental steps (Fig. 3). 
1.3.1  Attachment and entry  
To  initiate  infection  and  replication,  the  HA  protein  on  the  virus  surface 
attaches to the host cell receptors, containing terminal α-2,6 linked or α-2,3 
linked sialic acid (α-2,6-SA or α-2,3-SA). Avian and equine influenza viruses 
recognize  mainly  α-2,3-SA  receptors  (Gambotto  et  al.,  2008;  Horimoto  & 
Kawaoka, 2005; Connor et al., 1994). Humans have both type of receptors but 
human  viruses  can  mainly  recognize  α-2,6-SA  receptors  (Horimoto  & 
Kawaoka, 2006). Pigs, on their tracheal epithelial cells, have both (α-2, 6-SA 
or α-2, 3-SA) types of receptors, which may explain why they are susceptible 
to viruses from human and avian origin (Webster et al., 1992).  
Low pH 
(-)vRNA 
Nucleus 
(+)cRNA 
mRNA 
Fusion and uncoating  
Endocytosis 
Translation 
Post translatonal 
pocessing  
Packaging 
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Figure 3. To initiate infection and replication, the HA protein on the virus surface attaches to the 
host cell receptors. After cell attachment, the virus enters via receptor-mediated endocytosis, the 
viral RNPs (vRNP) are released into the cytoplasm and transported to the nucleus where viral 
RNA (vRNA) synthesis takes place. vRNAs are used as templates by the viral RNA polymerase, 
and  synthesize  two  kinds  of  positive-strand  RNAs.  Complementary  RNAs  (cRNAs)  are  full-
length copies of the vRNAs, and viral mRNAs are capped and polyadenylated and are exported to 
the  cytoplasm  for  translation.  Once  they  are  translated,  into  some  of  the  viral  proteins  are   20 
imported  back  to  the  nucleus  to  facilitate  replication  and  transcription.  After  that  newly 
synthesized RNPs are exported to the cytoplasm for packaging with the help of M1 and NEP. 
Viral HA, NA and M2 are matured in the Golgi apparatus (Golgi) and collecting at the plasma 
membrane where, with help of M1, the production of viral particles begins. As a consequence, 
budding  starts  and  the  progeny  virus  is  released  from  the  cell  by  the  activity  of  NA  that  is 
destroys receptors of the host and viral membranes. This is necessary for progeny virions to be 
released from the cell surface. 
1.3.2  Fusion and uncoating 
After cell attachment, the virus enters by the receptor-mediated endocytosis of 
the  virus  particle  via  clathrin-coated  pits  (this  process  is  dependent  on  a 
cellular GTPase) (Cross et al., 2001). The endocytosis formed vesicles with the 
viral particles fuse to the endosomes in the cytoplasm (Skehel & Wiley, 2000). 
Influenza  viruses  need  low  pH  to  fuse  with  endosomal  membranes.  After 
binding to the host cell surface and undergoing endocytosis, the low pH of the 
endosome activates fusion of the viral membrane with that of the endosome. 
The low pH (5.0) in the endosomes results in conformational changes of the 
HA molecules, and the HA monomers are cleaved by trypsin-like enzymes into 
HA1  (globular  domain)  and  HA2  (transmembrane  domain)  but  are  still 
attached  by  disulfide  bonds  (Skehel  et  al.,  1982).  The  concerted  structural 
change of the HA molecules opens up a pore, which releases the viral RNPs 
into  the  cytoplasm  of  the  cell.  Successful  uncoating  is  dependent  on  the 
presence of the M2 protein as well, which has ion channel activity (Pinto et al., 
1992).  It has been shown that amantadine and rimantadine can block both the 
M2 protein ion channel activity (Fig. 3) and uncoating and thus act as anti-
influenza drugs (Chizhmakov et al., 1996; Wang et al., 1993; Sugrue & Hay, 
1991). The HA-mediated fusion of the viral membrane with the endosomal 
membrane and the M2-mediated release of the RNP result in the appearance of 
free RNP complexes in the cytoplasm.  This completes the uncoating process 
(Martin & Helenius, 1991). 
1.3.3  Transcription and replication 
After the uncoating, the viral ribonucleoproteins (vRNPs) are transported into 
the nucleus (Helenius, 1992), where viral RNA synthesis takes place. Viral 
RNAs  (vRNAs)  are  used  as  templates  by  the  viral  RNA  polymerase,  and 
produce  two  kinds  of  positive-strand  RNAs  (Krug  et  al.,  1989). 
Complementary  RNAs  (cRNAs)  are  full-length  copies  of  the  vRNAs,  and 
mRNAs  are  capped  and  polyadenylated  (Shih  &  Krug,  1996;  Plotch  et  al., 
1981). The addition of the poly (A) tail occurs at a stretch of uridine residues 
close to the 5' end of the vRNAs. The mRNAs located at the 5' end of the   21 
vRNAs do not have genetic information. Amplification of the vRNA is done 
via copying of the full-length cRNAs into new full-length vRNA molecules. 
1.3.4  Assembly and release 
The mRNA travels from the nucleus into the cytoplasm and it’s translated into 
proteins.  The  translated  viral  proteins  that  are  needed  for  replication  and 
transcription  are  imported  back  into  the  nucleus  again.  After  that,  newly 
synthesized RNPs are exported to the cytoplasm for packaging, with help of 
the M1 and NEP. Viral HA, NA and M2 are matured in the Golgi apparatus 
(Golgi)  and  collect  at  the  plasma  membrane,  where  with  help  of  M1,  the 
production of viral particles begins. As a consequence, budding starts and the 
progeny virus is released from the cell by the activity of NA that is destroys 
receptors  of  the  host  and  viral  membranes.  This  is  necessary  for  progeny 
virions to be released from the cell surface. The NA is also the main target of 
the antiviral drugs zanamivir and oseltamivir. These inhibitors interfere with 
the activity of the NA protein (Fig. 3) that is crucial for efficient release from 
the cell surface and subsequent spread to other cells. 
1.4  Antigenic variation of influenza A viruses 
1.4.1  Drift  
Using two different mechanisms influenza A viruses continuously change their 
genetic  form/antigenicity.  The  viral  RNA  polymerase  does  not  have  proof 
reading activity when synthesizing the genome. This results in point mutations, 
called genetic drift (Both et al., 1983), the rate of mutations being about one 
nucleotide  change  for  one  copied  genome  (Drake,  1993).  The  highest 
evolutionary rates are observed in the HA and NA proteins. The antigenicity 
that the population develops drives the selection of the generated mutants and 
this  is  called  antigenic  drift.  Antigenic  drift  is  associated  with  seasonal 
epidemics, where new strains have amino acid changes in the HA and NA 
genes. These changes can overcome the existing immunity in humans, leading 
to seasonal influenza epidemics. 
1.4.2  Shift  
The influenza A virus genome is segmented, and when two or more different 
virus subtypes infect a single cell new strains can unexpectedly be produced by 
reassortment leading to antigenic shift. This is associated with the emergence 
of pandemic influenza viruses. This process is able to introduce new proteins, 
which can drastically change the biology of the virion. For example: it has 
played a huge role in the 1957 and 1968 pandemics, appearing with new PB1,   22 
HA  and/or  NA  proteins  to  which  the  human  population  was  not  immune 
(Scholtissek  et  al.,  1978).  The  best  example  of  this  is  the  2009  H1N1pdm 
(Fig.1).  
1.5  Reverse Genetics  
Because  influenza  viruses  are  negative  strand  RNA  viruses,  introduction  of 
genomic RNAs into cells does not result in the formation of an infectious virus 
(as is the case for positive strand RNA viruses). Experiments that have lead to 
the genetic engineering of influenza viruses have involved the reconstitution of 
functional RNP complexes in vitro (Parvin et al., 1989; Honda et al., 1987) and 
transfection of functional RNPs into cells. Reverse genetics (RG) for negative-
strand  RNA  viruses,  developed  for  influenza  viruses  (Enami  et  al.,  1990; 
Luytjes  et  al.,  1989),  has  dramatically  changed  our  understanding  of  the 
replication  cycles  of  these  viruses.  This  methodology  has  allowed  genetic 
manipulation of viral genomes in order to generate new viruses and elucidate 
their biological properties (Fodor et al., 1999). In many cases, the definitive 
role of a gene/domain (or even a single amino acid) can only be explored by 
introducing  appropriate  mutations  into  the  genome  of  the  virus  and  then 
analyzing the phenotype of the rescued virus. These techniques are currently 
being  used  in  several  research  areas  including:  i)  characterization  of  virus-
encoded virulence factors, ii) identification of virus-encoded antagonists of the 
interferon  system,  iii)  virus  replication  and  gene  expression,  iv)  immune 
regulation of influenza replication, and v) vaccine development. For example, 
the live attenuated pandemic H1N1 2009 vaccine was made from a plasmid-
generated strain, into which HA gene mutations were introduced to give high 
yields without changing the antigenicity of the strain (Chen et al., 2010) . 
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2  Aims of the study  
 
•  The  purpose  of  this  study  was  to  study  an  uncommon  SIV  H1N2 
subtype, isolated from a pig in a multisite herd, which was detected for 
the first time in Sweden during the winter of 2008-2009 (Paper I) 
 
•  In paper II, two consecutive SIV H1N2 isolates were compared, which 
adds further information about influenza epidemiology, and supports 
the necessity of surveillance for influenza viruses in pigs 
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3  Materials and Methods 
3.1  Clinical samples  
Lung or nasal swab samples from infected pigs were received by the National 
Veterinary Institute (SVA) for diagnostic investigation (Paper I & II). The sow 
pool was centrally located in Sweden at Moholm, 400 km from the southern 
coastline and 200 km from the western coastline, and the herd was located in 
Staffanstorp in southern Sweden. 
3.2  Virus isolation 
The virus was isolated from the clinical material by infecting primary swine 
kidney cells or Madin Darby Canine kidney (MDCK) cells, following standard 
cell  culture  procedures  (Papers  I,  II).  Viral  growth  was  determined  by  the 
observation of cytopathic effects (cpe), after 2– 4 days of incubation. The virus 
was aliquoted and stored at -70 ºC before use. 
3.3  RNA isolation and genomic sequence analysis 
Genetic analyses were conducted on the clinical material and on the MDCK 
cell isolates. Total RNA was prepared from virus-infected MDCK cells by the 
Qiagen RNeasy Mini kit, according to the manufacturer’s instructions (Qiagen, 
Hilden Germany) and amplified by one-step RT-PCR (QIAGEN One Step RT-
PCR Kit) using primers described previously (Kiss et al., 2008). Amplified 
products were purified using the Purification kit from Promega and sequenced 
using the fluorescent dye terminator method with an ABI PRISM Big DyeTM 
Terminator  Cycle  Sequencing  v3.1  Ready  Reaction  kit  (Perkin  Elmer, 
Waltham, MA, USA) on an ABI PRISM 310 genetic analyzer according to the 
manufacturer’s  recommendations  (Applied  Biosystems).  Both  strands  of  the   26 
amplicons were sequenced with the same forward and reverse primers as used 
for the amplification. Multiple alignments of the DNA sequences of each gene 
were performed using CLC, Main Workbench 5.0.2 (CLC bio A/S, Aarhus, 
Denmark). The data were transformed to MEGA format, and distance-based 
phylogenetic trees were generated using the MEGA vs 4.0 software (Tamura et 
al.,  2007)  with  1,000  bootstrap  replicates.  The  phylogenetic  trees  were 
constructed  with  the  Neighbour-joining  method  using  the  Kimura-two-
parameter  model.  The  results  were  verified  by  using  the  character  based 
method maximum parsimony, which showed similar topologies. 
3.4  Virus titration 
Viruses were analyzed by end-point titration through cpe using 96-well plates 
containing MDCK cells, in tenfold dilutions assaying eight replicates of 50µl 
per dilution, essentially according to (Stallknecht et al., 1990). The virus titres 
after 6–8 days were calculated according to (Kärber, 1931) and expressed as 
log10 tissue culture infectious dose (TCID)50 ml
-1. Haemagglutination (HA) 
titrations  were  performed  using  0.5%  chicken  erythrocytes  according  to 
(Abusugra et al., 1987) (Paper II). 
3.5  Biological titration assay and virus growth curves 
The plates were incubated up to 48 h, with microscopic evaluation of onset of 
cpe every 12 h. For the growth curves, primary foetal porcine kidney (FPK) 
cells were grown to about 80% confluency in Leighton tubes, using EMEM 
supplemented with non-essential amino acids (NEA) and containing 10% FBS. 
The tubes were inoculated with 50 µl of the three viruses, calculated to contain 
10
4 TCID50. Two tubes were frozen at -70 °C at regular intervals up to 216 h, 
with start at 0 h and subsequently from 48 h where onset of cpe could be seen 
(Paper II). 
3.6  Neuraminidase activity and inhibition assay 
The NA enzyme activity and drug inhibition assays were based on (Potier et 
al., 1979), with methylumbelliferone nacetylneuraminic acid (MUNANA) as 
the  substrate.  The  avian  influenza  strains,  which  have  been  shown  to  be 
oseltamivir  resistant  and  oseltamivir  susceptible,  were  used  as  positive 
controls.  The  NA  activity  was  plotted  using  GraphPad  Prism  Version  5 
software. The oseltamivir resistant and oseltamivir susceptible H1N1 strains 
were kindly provided by Prof. Björn Olsen at Uppsala University, Department of
Medical Sceinces, Section of infectious Diseases (PaperII).   27 
4  Results and discussion 
4.1  Papers I & II 
In  this  thesis  the  analysis  of  the  whole  genome  sequences  from  two  SIV 
isolates from Sweden in 2009 and 2010 were done (Metreveli et al., 2011). The 
sequence  comparison  revealed  significant  differences  between  the  two 
consecutive  H1N2  isolates.  The  most  remarkable  of  these  was  a  truncated 
coding region for PB1-F2 in the earlier isolates and a full-length coding region 
in the more recent isolates. The majority of avian influenza viruses and many 
SIVs harbour a 90 amino acid (aa) (full length) protein, while human viruses 
collected since 1950 have a 57 aa truncated PB1-F2 protein. The minority of 
the European SIVs have stop codons after 11, 25 and 43 aa (Zell et al., 2007). 
The 2009 Swedish H1N2 virus coded for a 57 aa truncated version of this 
protein, while the 2010 isolate coded for the 90 aa full length protein. 
Another protein that has implications in the host range of influenza viruses, due 
to its role in host immune evasion, is the non-structural protein (NS1). The 
NS1  sequence  of  sw-  H1N2-2009  and  2010  has  an  unusual  PDZ  binding 
domain (RPKV) at the C-terminal of the protein. It has recently been shown 
that the C-terminal four residues of the NS1 protein is a PDZ ligand domain of 
the X-S/T X-V type and may represent a virulence determinant (Ghedin et al., 
2005). This particular PDZ domain has been reported in only three cases, all in 
human isolates, but never in swine isolates. To our knowledge, this is the first 
reported isolation of this unusual PDZ binding domain in a pig population. 
More studies are needed to determine the exact function of the PDZ motif, and 
may help to determine and understand the function of the PDZ binding domain. 
One  recent  study  (Moreno  et  al.,  2011)  has  shown  that  novel  H1N2  swine 
influenza reassortants have derived from the 2009 H1N1pdm, with 7 genes 
well adapted to humans and the NA gene closely related to the Swedish 2009-
2010 H1N2 SIVs (Moreno et al., 2012). This new Italian H1N2 reassortant   28 
virus confirms the function of swine as mixing vessels for animal and human 
influenza, resulting in reassortment and host adaptation. This shows that the 
introduction  of  the  2009  H1N1pdm  in  the  swine  population  has  given 
opportunities for reassortment facilitating the alteration of transmissibility and 
increased  virulence  in  the  2009  H1N1pdm  virus.  Genetic  reassortment 
involving  a  virus  having  genes  specific  for  replication  in  a  new  host,  e.g. 
humans,  can  result  in  interspecies  transmission.  If  the  2009  H1N1pdm  is 
established  in  the  swine  population,  reassortment  could  occur  between 
influenza viruses both of mammal and avian origin, resulting in new variants 
with key molecular determinants of pathogenicity that are concern for public 
health (Neumann et al., 2009). All of these facts could have a great impact in 
southern Sweden where most of swine and poultry are raised and where we 
have diagnosed for the first time these uncommon avian-like reassortant H1N2 
SIV variants. Clearly, it is very important to analyze the whole genome of an 
IV isolate and to identify amino acid changes, and possibly their effect on the 
virus’s  life  cycle.  It  has  been  recognized  that  it  is  vital  for  a  “successful” 
reassortant to obtain functionally compatible gene segments. For example, the 
interaction of NP with PB2 and PB1, two subunits of the viral polymerase 
complex is crucial for efficient viral replication. To allow better spread among 
infected cells IV HA has to have a matching NA (Baigent & McCauley, 2001). 
The role of host cellular factors in IV replication is at least as important as all 
of the other components of the virus (Karlas et al., 2010; Konig et al., 2010).  
In summary, the avian-like reassortant H1N2 SIV variant appears to be gaining 
a  stronger  foothold  among  Swedish  pig  populations,  and  producing  more 
clinical disease. The molecular genomic differences found here indicate that 
the virus population is steadily evolving. In order to determine the effect of this 
virus  evolution  on  the  swine  industry  and  on  influenza  ecology,  further 
surveillances and detailed analyses are needed. 
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5  Implications for future research, 
concluding remarks 
Swine IVs should be systematically followed, because of the potential of swine 
to host rearrangement of the viral gene segments, so called reassortment, of 
porcine, avian and human origin. European avian-like SIV appears to be one of 
the ancestors of the H1N1pdm influenza virus that appeared in 2009. Since 
these unique reassortant variants of swine influenza virus may have a global 
importance as possible factors in the development of new pandemics, it would 
be  of  great  benefit  to  further  investigate  these  viruses  regarding  their 
replication  characteristics,  genetic  variability,  virulence  factors  and  immune 
modulation  capacity  in  both  swine  and  human  cells.  The  association  of 
truncated and full forms of PB1-F2 and their biological implications for viral 
pathogenicity  will  be  investigated  in  the  future  by  using  RG  system.  The 
advances  of  RG  techniques  have  been  of  great  value  for  the  study  of 
structure/function  of  different  influenza  virus  genes  and  their  proteins. 
Improved knowledge on all of these aspects of swine IVs will strongly benefit 
agribusiness and science and be of great importance for public health as well. 
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